{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:34:50Z","timestamp":1760236490000,"version":"build-2065373602"},"reference-count":32,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Microorganisms"],"abstract":"<jats:p>To assess the prevalence of COVID-19 in people living with HIV (PLWHIV), we performed an epidemiological survey from 1 April through 1 August 2020 in an HIV reference center in Northern France. PLWHIV completed a questionnaire about risk exposures and symptoms consistent with COVID-19 and performed a SARS-CoV-2 serology. Among the 600 PLWHIV included, 16 have been infected with SARS-CoV-2. Symptoms consistent with COVID-19 were frequent both in SARS-CoV-2 positive and negative patients (67% vs. 32%, p = 0.02). Among SARS-CoV-2 infected patients, one (6%) has been hospitalized and five (31%) have been asymptomatic. Close contact with a confirmed COVID-19 case was the only factor associated with COVID-19 acquisition (40% vs. 13%, p = 0.01). The prevalence of COVID-19 in PLWHIV was 2.5%, half of the overall population estimate after the first wave of the pandemic in France. In conclusion, proportion of asymptomatic COVID-19 was high in PLWHIV. The prevalence of COVID-19 in PLWHIV was two times lower than in the general population.<\/jats:p>","DOI":"10.3390\/microorganisms9122491","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T02:40:02Z","timestamp":1638412802000},"page":"2491","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["History of COVID-19 Symptoms and Seroprevalence of SARS-CoV-2 Antibodies in HIV-Infected Patients in Northern France after the First Wave of the Pandemic"],"prefix":"10.3390","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7233-0602","authenticated-orcid":false,"given":"Agn\u00e8s","family":"Meybeck","sequence":"first","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Huleux","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macha","family":"T\u00e9tart","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Thill","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent","family":"Derdour","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurence","family":"Bocket","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie, CHRU de Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enagnon Kazali","family":"Alidjinou","sequence":"additional","affiliation":[{"name":"Laboratoire de Virologie, CHRU de Lille, 59000 Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1262-5430","authenticated-orcid":false,"given":"Pierre","family":"Patoz","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Robineau","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiza","family":"Ajana","sequence":"additional","affiliation":[{"name":"Service des Maladies Infectieuses et du Voyageur, Centre Hospitalier de Tourcoing, 59200 Tourcoing, France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.jinf.2020.03.041","article-title":"Clinical characteristics of coronavirus disease 2019 (COVID-19) in China: A systematic review and meta-analysis","volume":"80","author":"Fu","year":"2020","journal-title":"J. Infect."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s15010-020-01492-7","article-title":"COVID-19 in patients with HIV-1 infection: A single-centre experience in northern Italy","volume":"49","author":"Calza","year":"2021","journal-title":"Infection"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/hiv.12911","article-title":"Coronavirus disease 2019 (COVID-19) outcomes in HIV\/AIDS patients: A systematic review","volume":"21","author":"Cooper","year":"2020","journal-title":"HIV Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e554","DOI":"10.1016\/S2352-3018(20)30164-8","article-title":"COVID-19 ID Team. Description of COVID-19 in HIV-infected individuals: A single-centre, prospective cohort","volume":"7","author":"Vizcarra","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0000000000002639","article-title":"COVID-19 attack rate in HIV-infected patients and in PrEP users","volume":"34","author":"Charre","year":"2020","journal-title":"AIDS"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1001\/archinte.161.3.441","article-title":"Excess mortality due to pneumonia or influenza durin influenza seasons among persons with acquired immunodeficiency syndrome","volume":"161","author":"Lin","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"Trial of lopinavir-ritonavir in adults hospitalized with severe COVID-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, remdesivir, galidesivir, and tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (PdRp): A molecular docking study","volume":"253","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"ref_11","unstructured":"DICOM_Jocelyne, M. (2020, May 10). Dans les Etablissements de Sant\u00e9: Recommandations COVID-19 et Prise en Charge [Internet] Minist\u00e8re des Solidarit\u00e9s et de la Sant\u00e9. Available online: https:\/\/solidarite-sante.gouv.fr\/soins-et-maladies\/maladies-infectieuses\/coronavirus\/professionnels-de-sante\/article\/dans-les-etablissements-de-sante-recommandations-covid-19-et-de-prise-en-charge."},{"key":"ref_12","first-page":"299","article-title":"NADIS 2000, development of an electronic medical record for patients infected by HIV, HBV and HCV","volume":"32","author":"Pugliese","year":"2003","journal-title":"Presse Med."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Grzelak, L., Temmam, S., Planchais, C., Demeret, C., Tondeur, L., Huon, C., Guivel-Benhassine, F., Staropoli, I., Chazal, M., and Dufloo, J. (2020). SARS-CoV-2 serological analysis of COVID-19 hospitalized patients, pauci-symptomatic individuals and blood donors. MedRxiv, preprint.","DOI":"10.1101\/2020.04.21.20068858"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"eabc3103","DOI":"10.1126\/scitranslmed.abc3103","article-title":"A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations","volume":"12","author":"Grzelak","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1126\/science.abc3517","article-title":"Estimating the burden of SARS-CoV-2 in France","volume":"369","author":"Salje","year":"2020","journal-title":"Science"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","volume":"26","author":"Long","year":"2020","journal-title":"Nat. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102915","DOI":"10.1016\/j.ebiom.2020.102915","article-title":"Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France","volume":"59","author":"Bruel","year":"2020","journal-title":"EbioMedicine"},{"key":"ref_18","first-page":"CD013652","article-title":"Antibody tests for identification of current and past infection with SARS-CoV-2","volume":"6","author":"Deeks","year":"2020","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Huang, J., Xie, N., Hu, X., Yan, H., Ding, J., Liu, P., Ma, H., Ruan, L., Li, G., and He, N. (2020). Epidemiological, virological and serological features of COVID-19 cases in people living with HIV in Wuhan City: A population-based cohort study. Clin. Infect. Dis., ciaa1186.","DOI":"10.1093\/cid\/ciaa1186"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/irv.12620","article-title":"Influenza epidemics observed in primary care from 1984 to 2017 in France: A decrease in epidemic size over time","volume":"13","author":"Souty","year":"2019","journal-title":"Influenza Other Respir. Viruses"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2000326","DOI":"10.2807\/1560-7917.ES.2020.25.14.2000326","article-title":"Excess cases of influenza-like illnesses synchronous with coronavirus disease (COVID-19) epidemic, France, March 2020","volume":"25","author":"Boelle","year":"2020","journal-title":"Eur. Surveill."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"713","DOI":"10.2217\/bmm-2020-0201","article-title":"Cardiovascular disease as a biomarker for an increased risk of COVID-19 infection and related poor prognosis","volume":"14","author":"Lelapi","year":"2020","journal-title":"Biomark. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/jmv.26352","article-title":"SARS-CoV-2 infection in persons living with HIV: A single center prospective cohort","volume":"93","author":"Maggiolo","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e25489","DOI":"10.1002\/jia2.25489","article-title":"Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID-19: Initial assessment","volume":"23","author":"Ford","year":"2020","journal-title":"J. Int. AIDS Soc."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e314","DOI":"10.1016\/S2352-3018(20)30111-9","article-title":"COVID-19 in HIV Investigators. COVID-19 in patients with HIV: Clinical case series","volume":"7","author":"Blanco","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s15010-020-01438-z","article-title":"COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients","volume":"48","author":"Spinner","year":"2020","journal-title":"Infection"},{"key":"ref_27","first-page":"e524","article-title":"A Survey for COVID-19 among HIV\/AIDS Patients in Two Districts of Wuhan, China","volume":"7","author":"Guo","year":"2020","journal-title":"Lancet"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1093\/cid\/ciaa1339","article-title":"Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients with HIV and Coronavirus Disease-19","volume":"73","author":"Dandachi","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/QAI.0000000000002423","article-title":"Outcomes among HIV-Positive patients hospitalized with COVID-19","volume":"85","author":"Carlucci","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/cid\/ciaa579","article-title":"Clinical features and outcomes of HIV patients with coronavirus disease 2019","volume":"71","author":"Gervasoni","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","unstructured":"BHIVA, DAIG, EACS, GESIDA, and Polish Scientific AIDS Society (2020, November 15). Statement on Risk of COVID-19 for People Living with HIV (PLWH). Available online: https:\/\/www.eacsociety.org."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Vena, A., Berruti, M., Adessi, A., Blumetti, P., Brignole, M., Colognato, R., Gaggioli, G., Giacobbe, D.R., Bracci-Laudiero, L.B., and Magnasco, L. (2020). Prevalence of antibodies to SARS-CoV-2 in Italian adults and associated risk factors. J. Clin. Med., 9.","DOI":"10.3390\/jcm9092780"}],"container-title":["Microorganisms"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/12\/2491\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:38:27Z","timestamp":1760168307000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-2607\/9\/12\/2491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["microorganisms9122491"],"URL":"https:\/\/doi.org\/10.3390\/microorganisms9122491","relation":{},"ISSN":["2076-2607"],"issn-type":[{"type":"electronic","value":"2076-2607"}],"subject":[],"published":{"date-parts":[[2021,12,1]]}}}